Dark

Check out our Level2View

CTDH
Cyclo Therapeutics, Inc. Common Stock
stock OTC

Inactive

Dec 8, 2020

0.0860USD+36.508%(+0.0230)452,996

Pre-market

0.00USD-100.000%(-0.08)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Nov 19, 2020

08:00AM EST Cyclo Therapeutics Announces Two Presentations at WORLDSymposium2021 Business Wire

Oct 21, 2020

10:57AM EDT Cyclo Therapeutics Phase 3 Pivotal Program Can Begin Enrollment Per US FDA RTTNews

Sep 21, 2020

08:00AM EDT Cyclo Therapeutics to Present at 2020 Annual Conference for NPC Patients, Families, and Health Professionals in the United Kingdom Business Wire

Sep 8, 2020

08:38AM EDT Cyclo Therapeutics Inc. Announces Additional Efficacy Data from its Ongoing Phase I/II Trial using Trappsol(r) CycloTM Intravenously to Treat Patients with Niemann-Pick Disease Type C1 (NPC1) Business Wire

Aug 27, 2020

08:12AM EDT Cyclo Therapeutics Closes $2.8 Mln Private Placement Led By Novit LP With $1.0 Mln RTTNews

08:00AM EDT Cyclo Therapeutics Closes $2.8 Million Private Placement Led by Novit LP With $1.0 Million Business Wire

Share